Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
1. D 600
2. D-600
3. D600
4. Elgiprona
5. Gallobeta
6. Gallopamil
7. Gallopamil Von Ct
8. Hydrochloride, Gallopamil
9. Methoxyverapamil
10. Prebet
11. Procorum
1. 16662-46-7
2. Procorum
3. Gallopamil Hcl
4. Methoxyverapamil Hydrochloride
5. Gallopamil (hydrochloride)
6. 5-((3,4-dimethoxyphenethyl)(methyl)amino)-2-isopropyl-2-(3,4,5-trimethoxyphenyl)pentanenitrile Hydrochloride
7. (+/-)-methoxyverapamil Hydrochloride
8. Vt4vr32a0t
9. Mls000069359
10. Methoxyverapamil (hydrochloride)
11. Nsc-274966
12. Smr000058477
13. [3-cyano-3-(3,4,5-trimethoxyphenyl)hex-6-yl]-(5,6-dimethoxyphenethyl)methylammonium Chloride
14. Dsstox_cid_27844
15. Dsstox_rid_82597
16. Dsstox_gsid_47858
17. 5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-yl-2-(3,4,5-trimethoxyphenyl)pentanenitrile;hydrochloride
18. 5-[2-(3,4-dimethoxyphenyl)ethyl-methylamino]-2-propan-2-yl-2-(3,4,5-trimethoxyphenyl)pentanenitrile;hydron;chloride
19. Gallopamil Hydrochloride (jan)
20. Gallopamil Hydrochloride [jan]
21. (3-cyano-3-(3,4,5-trimethoxyphenyl)hex-6-yl)-(5,6-dimethoxyphenethyl)methylammonium Chloride
22. 5-((3,4-dimethoxyphenethyl)(methyl)amino)-2-isopropyl-2-(3,4,5-trimethoxyphenyl)pentanenitrile Hcl
23. Cas-16662-46-7
24. D 600 Hydrochloride
25. Ncgc00015686-05
26. Einecs 240-704-7
27. Unii-vt4vr32a0t
28. Nsc 274966
29. D600; Gallopamil
30. Opera_id_1611
31. D-600 Hydrochloride
32. (+/-)-methoxyverapamil Hcl
33. Benzeneacetonitrile, Alpha-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4,5-trimethoxy-alpha-(1-methylethyl)-, Monohydrochloride
34. Schembl194931
35. Chembl1256940
36. Dtxsid2047858
37. (?)-methoxyverapamil Hydrochloride
38. (y)-methoxyverapamil Hydrochloride
39. Tox21_110196
40. Tox21_500778
41. Gallopamil Hydrochloride [mi]
42. Hy-14276a
43. Mfcd00058000
44. Nsc274966
45. Akos015994622
46. Tox21_110196_1
47. Ccg-222082
48. Hs-0066
49. Lp00778
50. Gallopamil Hydrochloride [mart.]
51. Gallopamil Hydrochloride [who-dd]
52. Ncgc00015686-11
53. Ncgc00094115-01
54. Ncgc00261463-01
55. Lu-30029
56. Cs-0109891
57. Eu-0100778
58. Ft-0727258
59. Ft-0772263
60. (+/-)-methoxyverapamil Hydrochloride, >=98%
61. D01969
62. I11594
63. M 5644
64. Sr-01000000018
65. J-010303
66. Sr-01000000018-2
67. Q27095539
68. ( Inverted Question Mark)-methoxyverapamil Hydrochloride
69. (+/-)-alpha-[3-[(2-(3,4-dimethoxyphenyl)ethyl)methylamino]propyl]-3,4,5-trimethoxy-alpha-(1-methylethyl)benzeneacetonitrile Hydrochloride
70. .alpha.-(3-((2-(3,4-dimethoxyphenyl)ethyl)methylamino)propyl)-3,4,5-trimethoxy-.alpha.-(1-methylethyl)benzeneacetonitrile Hydrochloride
71. .alpha.-isopropyl-.alpha.-((n-methyl-n-homoveratryl)-.gamma.-aminopropyl)-3,4,5-trimethoxyphenylacetonitrile Hydrochloride
72. 5-(3,4-dimethoxyphenethyl) Methylamino-2-isopropyl-2-(3,4,5-trimethoxyphenyl)-valeronitrile Hydrochloride
| Molecular Weight | 521.1 g/mol |
|---|---|
| Molecular Formula | C28H41ClN2O5 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 14 |
| Exact Mass | 520.2704001 g/mol |
| Monoisotopic Mass | 520.2704001 g/mol |
| Topological Polar Surface Area | 73.2 Ų |
| Heavy Atom Count | 36 |
| Formal Charge | 0 |
| Complexity | 639 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Calcium Channel Blockers
A class of drugs that act by selective inhibition of calcium influx through cellular membranes. (See all compounds classified as Calcium Channel Blockers.)
Global Sales Information
ABOUT THIS PAGE
A Gallopamil manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Gallopamil, including repackagers and relabelers. The FDA regulates Gallopamil manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Gallopamil API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Gallopamil supplier is an individual or a company that provides Gallopamil active pharmaceutical ingredient (API) or Gallopamil finished formulations upon request. The Gallopamil suppliers may include Gallopamil API manufacturers, exporters, distributors and traders.
click here to find a list of Gallopamil suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Gallopamil DMF (Drug Master File) is a document detailing the whole manufacturing process of Gallopamil active pharmaceutical ingredient (API) in detail. Different forms of Gallopamil DMFs exist exist since differing nations have different regulations, such as Gallopamil USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Gallopamil DMF submitted to regulatory agencies in the US is known as a USDMF. Gallopamil USDMF includes data on Gallopamil's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Gallopamil USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Gallopamil suppliers with USDMF on PharmaCompass.
Gallopamil Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Gallopamil GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Gallopamil GMP manufacturer or Gallopamil GMP API supplier for your needs.
A Gallopamil CoA (Certificate of Analysis) is a formal document that attests to Gallopamil's compliance with Gallopamil specifications and serves as a tool for batch-level quality control.
Gallopamil CoA mostly includes findings from lab analyses of a specific batch. For each Gallopamil CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Gallopamil may be tested according to a variety of international standards, such as European Pharmacopoeia (Gallopamil EP), Gallopamil JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Gallopamil USP).
LOOKING FOR A SUPPLIER?
